{"id":5108,"date":"2023-11-01T07:01:37","date_gmt":"2023-11-01T12:01:37","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=5108"},"modified":"2023-11-01T07:01:40","modified_gmt":"2023-11-01T12:01:40","slug":"a-chikungunya-vaccine-is-nearing-approval-who-will-get-it","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2023\/11\/01\/a-chikungunya-vaccine-is-nearing-approval-who-will-get-it\/","title":{"rendered":"A chikungunya vaccine is nearing approval. Who will get it?"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p><a href=\"https:\/\/www.science.org\/content\/article\/chikungunya-vaccine-nearing-approval-who-will-get-it\">Science<\/a> U.S. travelers at risk of getting the disease are first in line. <\/p>\n\n\n\n<p>The first vaccine against the mosquito-borne viral disease chikungunya will likely come to market next month. With the debilitating disease now afflicting more than half the countries in the world and threatening to spread further, the imminent U.S. Food and Drug Administration (FDA) approval of the vaccine is \u201cgreat news,\u201d says Scott Weaver, a virologist at the University of Texas Medical Branch whose own lab started to work on a chikungunya vaccine nearly 2 decades ago.<\/p>\n\n\n\n<p>The vaccine, made by the French company&nbsp;<a href=\"https:\/\/valneva.com\/press-release\/valneva-announces-pdufa-date-extension-for-chikungunya-virus-vaccine-candidate\/\">Valneva<\/a>, will likely be recommended mainly to U.S. travelers at first. But many expect an FDA approval will also grease the wheels for the vaccine to become available in the most affected countries.<\/p>\n\n\n\n<p><a href=\"https:\/\/academic.oup.com\/trstmh\/article-abstract\/51\/3\/238\/1895339?redirectedFrom=fulltext&amp;login=false\">First documented<\/a>\u00a0in 1952 in modern-day Tanzania, chikungunya means \u201cdisease that bends up the joints\u201d in Kimakonde, an East African language. Although rarely fatal, chikungunya virus causes long-term, debilitating joint pain in up to 40% of people it infects, most of whom live in warm climates that have large populations of two mosquito species,\u00a0<em>Aedes aegypti<\/em>\u00a0and\u00a0<em>A. albopictus<\/em>.\u00a0<a href=\"https:\/\/www.cdc.gov\/chikungunya\/geo\/chikungunya-in-the-us.html\">Almost all cases in the United States<\/a>\u00a0have been in travelers who have returned from affected countries.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.science.org\/content\/article\/chikungunya-vaccine-nearing-approval-who-will-get-it\">Continue reading<\/a><\/p>\n<!-- <a rel=\"nofollow\" href=\"\/secure-location.php\" title=\"TqFoxB  mHx m  soEBWW\">TqFoxB  mHx m  soEBWW<\/a> --><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Science U.S. travelers at risk of getting the disease are first in line. The first vaccine against the mosquito-borne viral disease chikungunya will likely come to market next month. With the debilitating disease now afflicting more than half the countries in the world and threatening to spread further, the imminent U.S. Food and Drug Administration [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":5109,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[],"class_list":["post-5108","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-emerging-infectious-diseases"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-content\/uploads\/2023\/11\/Screenshot-2023-11-01-at-08.00.12.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/5108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=5108"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/5108\/revisions"}],"predecessor-version":[{"id":5110,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/5108\/revisions\/5110"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media\/5109"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=5108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=5108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=5108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}